These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26415921)

  • 21. [Castleman's disease, HIV and rituximab].
    Valencia ME; López V; Corcuera MT; Del Val D
    Rev Clin Esp; 2012 Feb; 212(2):118-9. PubMed ID: 21924712
    [No Abstract]   [Full Text] [Related]  

  • 22. Desensitization protocol for rituximab-induced serum sickness.
    Fajt ML; Petrov AA
    Curr Drug Saf; 2014; 9(3):240-2. PubMed ID: 24861993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor.
    Della-Torre E; Conti A; Berti A; Yacoub MR; Alessio M
    Int J Rheum Dis; 2017 Feb; 20(2):276-279. PubMed ID: 28036157
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction.
    YIlmaz I; Türk M; Nazik Bahçecioğlu S
    Eur Ann Allergy Clin Immunol; 2018 Mar; 50(2):94-96. PubMed ID: 29384104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Desensibilización a Rituximab en paciente con proteinuria persistente secundaria a LES].
    Servín-Suárez N; Méndez-Gómez A; Korkowski-Uviña K; Carrillo-Murillo H; Torres-Rojo E; Ortega-Cisneros M; Ochoa-García IV
    Rev Alerg Mex; 2023 Sep; 70(4):. PubMed ID: 37933938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.
    Jain P; Verstovsek S; Loghavi S; Jorgensen JL; Patel KP; Estrov Z; Fayad L; Pemmaraju N
    Am J Hematol; 2015 Nov; 90(11):1091-2. PubMed ID: 25808231
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high-dose melphalan--two case studies.
    Jerkeman M; Lindén O
    Eur J Haematol; 2016 May; 96(5):541-3. PubMed ID: 26256458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol.
    Pérez-Rodríguez E; Martínez-Tadeo JA; Pérez-Rodríguez N; Hernández-Santana G; Callero-Viera A; Rodríguez-Plata E; García-Robaina JC
    J Allergy Clin Immunol Pract; 2018; 6(5):1621-1627.e6. PubMed ID: 29361511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
    Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid desensitization for hypersensitivity reactions to medications.
    Castells M
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):585-606. PubMed ID: 19563999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Warfarin desensitization. A case report].
    Fuentes-Abreu FS; Ardila-Herrera JC; Raigosa M
    Rev Alerg Mex; 2021; 68(1):80-83. PubMed ID: 34148331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
    Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
    Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization to inhaled aztreonam lysine in an allergic patient with cystic fibrosis using a novel approach.
    Guglani L; Abdulhamid I; Ditouras J; Montejo J
    Ann Pharmacother; 2012 Oct; 46(10):e25. PubMed ID: 23012384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Castleman's disease.
    Slotwiner A; Garwacki CP; Moll S
    Am J Hematol; 2003 May; 73(1):64-5. PubMed ID: 12701124
    [No Abstract]   [Full Text] [Related]  

  • 36. Effective Desensitization to Tocilizumab in Delayed Hypersensitivity Reaction.
    Cortellini G; Mascella F; Simoncelli M; Lippolis D; Focherini MC; Cortellini F; Cherubini C; Gavioli B; Ballardini G
    Pharmacology; 2018; 102(1-2):114-116. PubMed ID: 29953985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.
    Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M
    BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Castleman's disease of the rectum: report of a case.
    Hata T; Ikeda M; Ikenaga M; Yasui M; Shingai T; Yamamoto H; Ohue M; Sekimoto M; Hoshida Y; Aozasa K; Monden M
    Dis Colon Rectum; 2007 Mar; 50(3):389-94. PubMed ID: 17171476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Castleman's disease and sarcoidosis, a rare association resulting in a "mixed" response: a case report.
    Mohammed A; Janku F; Qi M; Kurzrock R
    J Med Case Rep; 2015 Feb; 9():45. PubMed ID: 25884809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unicentric Castleman's disease in the orbit: A case report.
    Kang D; Lee J; Lee H; Baek S
    Indian J Ophthalmol; 2015 Jun; 63(6):555-7. PubMed ID: 26265656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.